Modular Medical, Inc.

General Information

(Note: This is NOT an IPO. This is a NASDAQ uplisting from the OTCQB market. IPOScoop has NO CALL on uplistings.)

Modular Medical is a development stage medical device company focused on the design, development, and commercialization of an innovative insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. Through the creation of a novel two-part patch pump, our MODD1 product candidate, or MODD1, the Company seeks to fundamentally alter the trade-offs between cost and complexity and access to the higher standards of care that presently available insulin pumps provide. By simplifying and streamlining the user experience from introduction, prescription, reimbursement, training and day-to-day use, we seek to expand the wearable insulin delivery device market beyond the highly motivated “super users” and expand the category into the mass market. The product candidate seeks to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

(Note: Net loss is for the six months ended Sept. 30, 2021.) 


Industry: Surgical & Medical Devices - Insulin Pumps
Contact Information
Address 16772 W. Bernardo Drive San Diego, California 92127
Phone Number 858) 800-3500
Web Address
View Prospectus: Modular Medical, Inc.
Financial Information
Market Cap $118.78mil
Revenues $0 mil (last 12 months)
Net Income $-9.22 mil (last 12 months)
IPO Profile
Symbol MODD
Exchange NASDAQ
Shares (millions): 2.4
Price range $12.49 - $12.49
Est. $ Volume $30.0 mil
Manager / Joint Managers Oppenheimer & Co.
CO-Managers The Benchmark Company/ Lake Street
Expected To Trade: 1/17/2022
Day: Week of
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change